JP2016503786A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016503786A5 JP2016503786A5 JP2015548838A JP2015548838A JP2016503786A5 JP 2016503786 A5 JP2016503786 A5 JP 2016503786A5 JP 2015548838 A JP2015548838 A JP 2015548838A JP 2015548838 A JP2015548838 A JP 2015548838A JP 2016503786 A5 JP2016503786 A5 JP 2016503786A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- triazol
- piperidine
- carboxylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 9
- 206010016654 Fibrosis Diseases 0.000 claims 6
- -1 3,5-dichlorobenzyl Chemical group 0.000 claims 5
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 208000002193 Pain Diseases 0.000 claims 3
- 208000003251 Pruritus Diseases 0.000 claims 3
- 208000006673 asthma Diseases 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 230000007882 cirrhosis Effects 0.000 claims 3
- 208000019425 cirrhosis of liver Diseases 0.000 claims 3
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 230000004761 fibrosis Effects 0.000 claims 3
- 208000017169 kidney disease Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- SKMSWZDQKZXGPM-UHFFFAOYSA-N (3,5-dichlorophenyl)methyl 4-[2-oxo-2-[2-(2h-triazol-4-yl)ethylamino]ethyl]piperidine-1-carboxylate Chemical compound ClC1=CC(Cl)=CC(COC(=O)N2CCC(CC(=O)NCCC=3N=NNC=3)CC2)=C1 SKMSWZDQKZXGPM-UHFFFAOYSA-N 0.000 claims 1
- GAMSNABJTRSYDT-UHFFFAOYSA-N (3,5-dichlorophenyl)methyl 4-[4-(2h-triazol-4-yl)butanoylamino]piperidine-1-carboxylate Chemical compound ClC1=CC(Cl)=CC(COC(=O)N2CCC(CC2)NC(=O)CCCC=2N=NNC=2)=C1 GAMSNABJTRSYDT-UHFFFAOYSA-N 0.000 claims 1
- BGTUNXZYEFXERH-UHFFFAOYSA-N (3,5-dichlorophenyl)methyl 4-[[3-(2h-triazol-4-yl)propanoylamino]methyl]piperidine-1-carboxylate Chemical compound ClC1=CC(Cl)=CC(COC(=O)N2CCC(CNC(=O)CCC=3NN=NC=3)CC2)=C1 BGTUNXZYEFXERH-UHFFFAOYSA-N 0.000 claims 1
- XZOSUJGCZYHQHE-UHFFFAOYSA-N (3,5-dichlorophenyl)methyl 4-[[4-(2h-triazol-4-yl)butanoylamino]methyl]piperidine-1-carboxylate Chemical compound ClC1=CC(Cl)=CC(COC(=O)N2CCC(CNC(=O)CCCC=3NN=NC=3)CC2)=C1 XZOSUJGCZYHQHE-UHFFFAOYSA-N 0.000 claims 1
- MTZCQEFEIXRSMB-UHFFFAOYSA-N [3-cyano-5-(trifluoromethoxy)phenyl]methyl 4-[4-(2h-triazol-4-yl)butanoylamino]piperidine-1-carboxylate Chemical compound N#CC1=CC(OC(F)(F)F)=CC(COC(=O)N2CCC(CC2)NC(=O)CCCC=2N=NNC=2)=C1 MTZCQEFEIXRSMB-UHFFFAOYSA-N 0.000 claims 1
- OTQCFKGHQGIJNY-UHFFFAOYSA-N [3-cyano-5-(trifluoromethyl)phenyl]methyl 4-[4-(2h-triazol-4-yl)butanoylamino]piperidine-1-carboxylate Chemical compound N#CC1=CC(C(F)(F)F)=CC(COC(=O)N2CCC(CC2)NC(=O)CCCC=2N=NNC=2)=C1 OTQCFKGHQGIJNY-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261739214P | 2012-12-19 | 2012-12-19 | |
| US61/739,214 | 2012-12-19 | ||
| US201361787796P | 2013-03-15 | 2013-03-15 | |
| US61/787,796 | 2013-03-15 | ||
| US201361903928P | 2013-11-13 | 2013-11-13 | |
| US61/903,928 | 2013-11-13 | ||
| PCT/IB2013/061047 WO2014097151A2 (en) | 2012-12-19 | 2013-12-17 | Autotaxin inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016503786A JP2016503786A (ja) | 2016-02-08 |
| JP2016503786A5 true JP2016503786A5 (OSRAM) | 2017-02-09 |
| JP6363616B2 JP6363616B2 (ja) | 2018-07-25 |
Family
ID=50070613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015548838A Expired - Fee Related JP6363616B2 (ja) | 2012-12-19 | 2013-12-17 | オートタキシン阻害剤 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US9630945B2 (OSRAM) |
| EP (1) | EP2935249B1 (OSRAM) |
| JP (1) | JP6363616B2 (OSRAM) |
| KR (1) | KR20150095888A (OSRAM) |
| CN (1) | CN104968656B (OSRAM) |
| AU (1) | AU2013365742B2 (OSRAM) |
| BR (1) | BR112015014372A8 (OSRAM) |
| CA (1) | CA2895448A1 (OSRAM) |
| CL (1) | CL2015001731A1 (OSRAM) |
| CR (1) | CR20150326A (OSRAM) |
| EA (1) | EA028509B1 (OSRAM) |
| ES (1) | ES2715682T3 (OSRAM) |
| HK (1) | HK1212348A1 (OSRAM) |
| IL (1) | IL239435A0 (OSRAM) |
| MX (1) | MX2015007936A (OSRAM) |
| PE (1) | PE20151067A1 (OSRAM) |
| PH (1) | PH12015501385A1 (OSRAM) |
| SG (1) | SG11201504633PA (OSRAM) |
| TN (1) | TN2015000278A1 (OSRAM) |
| TW (1) | TW201427946A (OSRAM) |
| UY (1) | UY35210A (OSRAM) |
| WO (1) | WO2014097151A2 (OSRAM) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI572605B (zh) | 2012-04-26 | 2017-03-01 | 必治妥美雅史谷比公司 | 血小板聚集之抑制劑 |
| TWI568722B (zh) | 2012-06-15 | 2017-02-01 | 葛蘭馬克製藥公司 | 作爲ｍＰＧＥＳ－１抑制劑之三唑酮化合物 |
| JP6437452B2 (ja) | 2013-01-14 | 2018-12-12 | インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ | Ｐｉｍキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物 |
| LT2945939T (lt) | 2013-01-15 | 2020-07-27 | Incyte Holdings Corporation | Triazolkarboksamidai ir piridinkarboksamido junginiai, naudotini kaip pim kinazės inhibitoriai |
| HK1225317A1 (zh) * | 2013-07-30 | 2017-09-08 | Glaxosmithkline Intellectual Property Development Limited | 用於治疗过度出汗的局部组合物及其使用方法 |
| EP3036238A1 (en) | 2013-08-23 | 2016-06-29 | Incyte Corporation | Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors |
| US9951026B2 (en) | 2013-09-17 | 2018-04-24 | Pharmakea, Inc. | Heterocyclic vinyl autotaxin inhibitor compounds |
| WO2015042053A1 (en) | 2013-09-17 | 2015-03-26 | Pharmakea, Inc. | Vinyl autotaxin inhibitor compounds |
| US9850203B2 (en) | 2013-09-26 | 2017-12-26 | Pharmakea, Inc. | Autotaxin inhibitor compounds |
| WO2015077503A1 (en) | 2013-11-22 | 2015-05-28 | Pharmakea, Inc. | Autotaxin inhibitor compounds |
| US9926318B2 (en) | 2013-11-22 | 2018-03-27 | Pharmakea, Inc. | Tetracyclic autotaxin inhibitors |
| US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
| US9822124B2 (en) | 2014-07-14 | 2017-11-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors |
| US9051320B1 (en) | 2014-08-18 | 2015-06-09 | Pharmakea, Inc. | Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor |
| KR102022866B1 (ko) * | 2014-08-19 | 2019-09-19 | 상하이 하이헤 파마수티컬 컴퍼니 리미티드 | 섬유 아세포 성장 인자 수용체 키나아제 억제제인 인다졸계 화합물 및 이의 제조와 응용 |
| CA2974311A1 (en) | 2015-01-20 | 2016-07-28 | Novartis Ag | Pet imaging agents |
| GB201501870D0 (en) * | 2015-02-04 | 2015-03-18 | Cancer Rec Tech Ltd | Autotaxin inhibitors |
| GB201502020D0 (en) | 2015-02-06 | 2015-03-25 | Cancer Rec Tech Ltd | Autotaxin inhibitory compounds |
| AU2016268250B2 (en) | 2015-05-27 | 2020-08-27 | Sabre Therapeutics Llc | Autotaxin inhibitors and uses thereof |
| US9540347B2 (en) | 2015-05-29 | 2017-01-10 | Incyte Corporation | Pyridineamine compounds useful as Pim kinase inhibitors |
| US10118904B2 (en) | 2015-06-05 | 2018-11-06 | Vertex Pharmaceuticals Incorporated | Triazoles for the treatment of Demyelinating Diseases |
| AR105967A1 (es) | 2015-09-09 | 2017-11-29 | Incyte Corp | Sales de un inhibidor de pim quinasa |
| WO2017059251A1 (en) | 2015-10-02 | 2017-04-06 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
| JP2019530678A (ja) | 2016-09-18 | 2019-10-24 | エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド | Ｙａｐ１のｏｃｔ４との相互作用を標的とするｙａｐ１阻害剤 |
| WO2018106641A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Pyrazoles for the treatment of demyelinating diseases |
| WO2018106646A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Aminotriazoles for the treatment of demyelinating diseases |
| WO2018106643A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Heterocyclic azoles for the treatment of demyelinating diseases |
| TW201924683A (zh) | 2017-12-08 | 2019-07-01 | 美商英塞特公司 | 用於治療骨髓增生性贅瘤的低劑量組合療法 |
| EA202092174A1 (ru) | 2018-03-14 | 2021-01-15 | Х. Ли Моффитт Кэнсер Сентер Энд Рисерч Инститьют, Инк. | Ингибиторы yap1, которые нацелены на взаимодействие yap1 с oct4 |
| GEP20237476B (en) | 2018-09-21 | 2023-03-27 | Pfizer | N-substituted-dioxocyclobutenylamino-3-hydroxypicolinamides useful as ccr6 inhibitors |
| CN114127054B (zh) | 2019-07-22 | 2024-04-09 | 勃林格殷格翰国际有限公司 | 作为用于治疗炎性气道或纤维化疾病的自分泌运动因子(atx)调节剂的n-甲基、n-(6-(甲氧基)哒嗪-3-基)胺衍生物 |
| US12383547B2 (en) | 2020-07-01 | 2025-08-12 | Vanderbilt University | Methods of treatment for a kidney disease |
| WO2022053651A2 (en) | 2020-09-10 | 2022-03-17 | Precirix N.V. | Antibody fragment against fap |
| KR102502940B1 (ko) * | 2021-11-30 | 2023-02-24 | 주식회사 넥스트젠바이오사이언스 | 오토탁신 저해제로서의 신규 화합물 및 이의 용도 |
| WO2023203135A1 (en) | 2022-04-22 | 2023-10-26 | Precirix N.V. | Improved radiolabelled antibody |
| IL318992A (en) | 2022-05-02 | 2025-04-01 | Precirix N V | Cancer treatment through advance directives |
| KR102587919B1 (ko) * | 2022-07-22 | 2023-10-11 | 주식회사 넥스트젠바이오사이언스 | 신규한 헤테로사이클릭 화합물 및 이를 포함하는 오토탁신 저해용 약학 조성물 |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1016489B (it) | 1974-03-18 | 1977-05-30 | Isf Spa | Inalatore |
| JPS58163382U (ja) | 1982-04-28 | 1983-10-31 | 有限会社森製作所 | 二輪車用ヘツドパ−ツ組立体 |
| US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
| JP3810097B2 (ja) | 1993-01-15 | 2006-08-16 | 明治製菓株式会社 | ピロリジン−２−イルカルボニル複素環式化合物誘導体 |
| US6596260B1 (en) | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
| US6051397A (en) | 1993-11-16 | 2000-04-18 | Max Planck Gesellschaft Zur Forderung Der Wissenschaften | DNA encoding MCK-10, a novel receptor tyrosine kinase |
| US6159938A (en) | 1994-11-21 | 2000-12-12 | Cortech, Inc. | Serine protease inhibitors comprising α-keto heterocycles |
| US6182655B1 (en) | 1995-12-07 | 2001-02-06 | Jago Research Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
| US6065472A (en) | 1996-01-03 | 2000-05-23 | Glaxo Wellcome Inc. | Multidose powder inhalation device |
| PL185384B1 (pl) | 1996-02-21 | 2003-04-30 | Schering Corp | Inhalator proszku |
| EP1105412A1 (en) | 1998-08-17 | 2001-06-13 | Cortech, Inc. | Serine protease inhibitors comprising alpha-keto heterocycles |
| US6100279A (en) | 1998-11-05 | 2000-08-08 | Schering Corporation | Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| GB9913083D0 (en) | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
| US7069929B2 (en) | 2000-02-01 | 2006-07-04 | Quadrant Technologies Limited | Dry powder inhaler |
| RU2247725C2 (ru) | 2000-11-16 | 2005-03-10 | Санкио Компани, Лимитед | Производные 1-метилкарбапенема |
| AU2002338334B8 (en) | 2001-04-03 | 2008-09-18 | Merck & Co., Inc. | N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists |
| CA2449249A1 (en) * | 2001-06-12 | 2002-12-19 | Merck & Co., Inc. | Nr2b receptor antagonists for the treatment or prevention of migraines |
| FR2829766A1 (fr) * | 2001-09-14 | 2003-03-21 | Lipha | Derives d'oxamates comportant un heterocycle azote diversement substitue |
| ES2201907B1 (es) | 2002-05-29 | 2005-06-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos. |
| JP2006096662A (ja) | 2002-09-18 | 2006-04-13 | Sumitomo Pharmaceut Co Ltd | 新規６−置換ウラシル誘導体及びアレルギー性疾患の治療剤 |
| JP2004107299A (ja) | 2002-09-20 | 2004-04-08 | Japan Energy Corp | 新規１−置換ウラシル誘導体及びアレルギー性疾患の治療剤 |
| CA2507026A1 (en) | 2002-11-22 | 2004-06-10 | Takeda Pharmaceutical Company Limited | Imidazole derivatives, their production and use |
| CA2514733A1 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| US7049323B2 (en) | 2003-04-25 | 2006-05-23 | Bristol-Myers Squibb Company | Amidoheterocycles as modulators of the melanocortin-4 receptor |
| DE602004016992D1 (de) | 2003-05-02 | 2008-11-20 | Elan Pharm Inc | 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3-carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen |
| WO2005016883A2 (en) | 2003-08-14 | 2005-02-24 | Icos Corporation | Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
| GB2407042B (en) | 2003-10-17 | 2007-10-24 | Vectura Ltd | Inhaler |
| TW200526641A (en) | 2003-12-26 | 2005-08-16 | Daiichi Seiyaku Co | Amidopyrazole derivatives |
| CN100589849C (zh) | 2004-02-24 | 2010-02-17 | 微计量技术有限公司 | 基于合成射流的药物输送方法和装置 |
| GB0410712D0 (en) | 2004-05-13 | 2004-06-16 | Novartis Ag | Organic compounds |
| GB0413960D0 (en) | 2004-06-22 | 2004-07-28 | Novartis Ag | Organic compounds |
| GB0424284D0 (en) | 2004-11-02 | 2004-12-01 | Novartis Ag | Organic compounds |
| GB0428416D0 (en) | 2004-12-24 | 2005-02-02 | Novartis Ag | Organic compounds |
| GB0428418D0 (en) | 2004-12-24 | 2005-02-02 | Novartis Ag | Organic compounds |
| AR052559A1 (es) | 2005-01-21 | 2007-03-21 | Astex Therapeutics Ltd | Derivados de pirazol para inhibir cdk's y gsk's |
| EP1891048A1 (en) | 2005-06-11 | 2008-02-27 | Vernalis (R&D) Limited | Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders |
| JP2008545009A (ja) | 2005-06-30 | 2008-12-11 | プロシディオン・リミテッド | Ｇｐｃｒアゴニスト |
| AU2006281497B2 (en) | 2005-08-15 | 2012-06-07 | F. Hoffmann-La Roche Ag | Piperidine and piperazine derivatives as P2X3 antagonists |
| EP1954137A4 (en) | 2005-11-18 | 2008-12-17 | Janssen Pharmaceutica Nv | 2-KETO-OXAZOLE AS MODULATORS OF FATTY ACID AMIDHYDROLASE |
| WO2007103719A2 (en) | 2006-03-03 | 2007-09-13 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| EP2668970B1 (en) | 2006-10-25 | 2016-07-06 | Novartis AG | Powder dispersion apparatus |
| DE102007047737A1 (de) * | 2007-10-05 | 2009-04-30 | Merck Patent Gmbh | Piperidin- und Piperazinderivate |
| DE102007047738A1 (de) | 2007-10-05 | 2009-04-09 | Merck Patent Gmbh | Imidazolderivate |
| JP5504171B2 (ja) | 2007-12-26 | 2014-05-28 | サノフイ | Ｐ２ｙ１２アンタゴニストとしてのヘテロサイクリックピラゾール−カルボキサミド |
| WO2009117112A2 (en) | 2008-03-21 | 2009-09-24 | Novartis Ag | Powder dispersion apparatus, method of making and using the apparatus, components that can be used on the apparatus and other devices, and various active agents |
| DE102008059578A1 (de) | 2008-11-28 | 2010-06-10 | Merck Patent Gmbh | Benzo-Naphtyridin Verbindungen |
| SG171809A1 (en) | 2008-12-01 | 2011-07-28 | Merck Patent Gmbh | 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer |
| WO2010097374A1 (de) | 2009-02-26 | 2010-09-02 | Boehringer Ingelheim International Gmbh | Verbindungen als bradykinin-b1-antagonisten |
| MX2011010203A (es) | 2009-04-02 | 2011-10-14 | Merck Patent Gmbh | Derivados de piperidina y piperazina como inhibidores de autotaxina. |
| JP5767205B2 (ja) * | 2009-04-02 | 2015-08-19 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | オートタキシン阻害剤としての複素環式化合物 |
| ES2547124T3 (es) | 2009-04-02 | 2015-10-01 | Merck Patent Gmbh | Inhibidores de autotaxina |
| DE102009033392A1 (de) | 2009-07-16 | 2011-01-20 | Merck Patent Gmbh | Heterocyclische Verbindungen als Autotaxin-Inhibitoren II |
| DE102009049211A1 (de) | 2009-10-13 | 2011-04-28 | Merck Patent Gmbh | Sulfoxide |
| EP2493297B1 (en) | 2009-10-30 | 2016-08-17 | Merck Sharp & Dohme Corp. | Heterocycle amide t-type calcium channel antagonists |
| EP2552914B1 (de) | 2010-03-26 | 2015-11-11 | Merck Patent GmbH | Benzonaphthyridinamine als autotaxin-inhibitoren |
| JP2013536200A (ja) | 2010-08-20 | 2013-09-19 | アミラ ファーマシューティカルス，インコーポレーテッド | オートタキシン阻害剤およびその使用 |
| WO2012068589A2 (en) | 2010-11-19 | 2012-05-24 | Constellation Pharmaceuticals | Modulators of methyl modifying enzymes, compositions and uses thereof |
| PT2861566T (pt) | 2012-06-13 | 2017-02-08 | Hoffmann La Roche | Novos diazaspirocicloalcanos e azaspirocicloalcanos |
| AU2013322838B2 (en) | 2012-09-25 | 2018-02-01 | F. Hoffmann-La Roche Ag | New bicyclic derivatives |
-
2013
- 2013-12-17 CN CN201380071957.9A patent/CN104968656B/zh not_active Expired - Fee Related
- 2013-12-17 JP JP2015548838A patent/JP6363616B2/ja not_active Expired - Fee Related
- 2013-12-17 WO PCT/IB2013/061047 patent/WO2014097151A2/en not_active Ceased
- 2013-12-17 PE PE2015001055A patent/PE20151067A1/es not_active Application Discontinuation
- 2013-12-17 AU AU2013365742A patent/AU2013365742B2/en not_active Ceased
- 2013-12-17 MX MX2015007936A patent/MX2015007936A/es unknown
- 2013-12-17 US US14/653,649 patent/US9630945B2/en not_active Expired - Fee Related
- 2013-12-17 KR KR1020157019063A patent/KR20150095888A/ko not_active Withdrawn
- 2013-12-17 HK HK16100333.8A patent/HK1212348A1/xx unknown
- 2013-12-17 BR BR112015014372A patent/BR112015014372A8/pt not_active Application Discontinuation
- 2013-12-17 ES ES13828825T patent/ES2715682T3/es active Active
- 2013-12-17 EA EA201591166A patent/EA028509B1/ru not_active IP Right Cessation
- 2013-12-17 SG SG11201504633PA patent/SG11201504633PA/en unknown
- 2013-12-17 US US14/109,935 patent/US20140171404A1/en not_active Abandoned
- 2013-12-17 CA CA2895448A patent/CA2895448A1/en not_active Abandoned
- 2013-12-17 EP EP13828825.3A patent/EP2935249B1/en active Active
- 2013-12-18 TW TW102147021A patent/TW201427946A/zh unknown
- 2013-12-19 UY UY0001035210A patent/UY35210A/es not_active Application Discontinuation
-
2015
- 2015-06-15 IL IL239435A patent/IL239435A0/en unknown
- 2015-06-16 TN TNP2015000278A patent/TN2015000278A1/fr unknown
- 2015-06-17 PH PH12015501385A patent/PH12015501385A1/en unknown
- 2015-06-18 CL CL2015001731A patent/CL2015001731A1/es unknown
- 2015-06-19 CR CR20150326A patent/CR20150326A/es unknown